The NRG Oncology Podcast

NRG-CC009 for Brain Mets from SCLC with Dr. Vinai Gondi

The NRG Oncology Podcast

Show Notes

NRG Oncology Podcast co-hosts talk with Dr. Vinai Gondi, the Principal Investigator of the NRG-CC009 phase III clinical study assessing stereotactic radiosurgery (SRS) versus hippocampal-avoidant whole brain radiotherapy (HA-WBRT) for patients who have brain metastases (or cancer that has spread to the brain) from their small cell lung cancer (SCLC).

More from The NRG Oncology Podcast

Oct 7, 2026

For Breast Cancer Awareness Month, we discuss the results of the NRG-BR002 in newly oligometastatic breast cancer published in the Journal of Clinical Oncology today.

Sep 29, 2026

We discuss the reported results of the NRG-HN009 p16-negative cohort presented at the ASTRO Annual Meeting Late-Breaking Abstract Session.

Sep 28, 2026

We discuss both the NRG-CC009 study results presented during the 2026 ASTRO Annual Meeting Plenary Session and the MAVERICK study results presented during the Clinical Trials Session.

Sep 28, 2026

We discuss the NRG-GI003 results presented during the 2026 ASTRO Annual Meeting Plenary Session.

Sep 27, 2026

We interview Dr. Shang "George" Zhao on the NRG-RTOG 0534 "SPPORT" study results he presented at the 2026 ASTRO Annual Meeting Clinical Trials Session.

See all episodes →